KalVista Pharmaceuticals/$KALV
About KalVista Pharmaceuticals
Ticker
Industry
Employees
KALV Metrics
$372M
-
-$3.66
0.83
-
Price and volume
Market cap
$372M
Beta
0.83
52-week high
$16.88
52-week low
$7.30
Average daily volume
347K
Financial strength
Current ratio
6.87
Quick ratio
6.709
Long term debt to equity
3.489
Total debt to equity
4.636
Management effectiveness
Return on assets (TTM)
-71.62%
Return on equity (TTM)
-125.90%
Valuation
Price to book
2.43
Price to tangible book (TTM)
2.43
Price to free cash flow (TTM)
-2.614
Growth
Earnings per share change (TTM)
19.41%
3-year earnings per share growth (CAGR)
10.42%
What the Analysts think about KALV
Analyst Ratings
KALV Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
KALV Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
KALV News
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KalVista: Potential First With Multiple Sebetralstat Regulatory Reviews In 2025
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update
FAQs
What’s the current market cap for KalVista Pharmaceuticals stock?
What is the P/E ratio for KalVista Pharmaceuticals stock?
Does KalVista Pharmaceuticals stock pay dividends?
No, KalVista Pharmaceuticals (KALV) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next KalVista Pharmaceuticals dividend payment date?
KalVista Pharmaceuticals (KALV) stock does not pay dividends to its shareholders.
What is the beta indicator for KalVista Pharmaceuticals?
KalVista Pharmaceuticals (KALV) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.